Case Report: Long-Term Response to Radiotherapy Combined With Targeted Therapy in Histiocytic Sarcoma Harboring Mutations in MAPK and PI3K/AKT Pathways

BACKGROUND: Histiocytic sarcoma (HS) is a rare hematopoietic malignancy with an aggressive clinical presentation associated with a poor overall survival. To date, surgical resection, radiation therapy, and chemotherapy were often utilized for HS, but curative effects are rather disappointing. CASE P...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zijian, Xiao, Yin, Liu, Xinxiu, Li, Qiuhui, Liu, Tao, Zhu, Fang, Wu, Gang, Zhang, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685210/
https://www.ncbi.nlm.nih.gov/pubmed/34938656
http://dx.doi.org/10.3389/fonc.2021.755893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685210/
https://www.ncbi.nlm.nih.gov/pubmed/34938656
http://dx.doi.org/10.3389/fonc.2021.755893

Ejemplares similares